🫀Fellow @MayoAZCVFellows 🌵☀️| @DartmouthHealth @OUWB @ASUEngineering | ☕ Coffee in hand, heart in collaboration & patient-centered care
Joined May 2020
- Tweets 407
- Following 349
- Followers 255
- Likes 1,918
40 Photos and videos
Lots of excitement and potential for high-risk PCI. Looking forward to seeing more data and, eventually, whether this tech can be expanded to cardiogenic shock cohort.
A novel low-profile (10F) percutaneous LV support device with up to 5.5 L/min demonstrates favorable performance and device-related safety in an early high-risk PCI feasibility study. The SUPPORT I Study. @azeemlatib @Kandzari ahajrnls.org/3QVIyzX
1
3
139
Girish Pathangey retweeted
Checkout our latest publications “Cannabidiol in Cardiovascular Disease: A Review of Current Evidence and Future Directions”
sciencedirect.com/science/ar…
@GPathangey
@ramziw_
@ChadiAyoub1
@MayoClinicCV
@MayoAZCVFellows
2
17
742
Girish Pathangey retweeted
18 Dec 2025
Honored and excited to join this @ACCinTouch committee as a fellow-in-training and learn from the outstanding group of EP faculty! 🫀
@MayoAZCVFellows @MayoClinic
6
1
20
1,263
Girish Pathangey retweeted
14 Dec 2025
Honored to serve as a Member of the Fellows in Training (FIT) Section Leadership Council 🫀 @ACCinTouch
Grateful for the support @MayoClinicCV
@MayoAZCVFellows
#ACCFIT
#AHAFIT
#cardiotwitter
4
2
37
2,651
#mdpijcm
#LatestPaper Sharing
#GraphicalAbstract
Beyond Lipids and Platelets: A Review of Anti-Inflammatory Strategies in Secondary Prevention of #AcuteCoronarySyndromes
👉mdpi.com/3579950
👥@GPathangey @M_H_Abdelnabi
🏬@MayoClinic
@MediPharma_MDPI
2
5
218
Girish Pathangey retweeted
4 Dec 2025
We are excited to welcome our incoming fellows. Congratulations! We’re honored to have you and look forward to an incredible journey ahead in sunny AZ ☀️ #ACCFIT #CardioTwitter 🫀
5
11
178
39,880
11 Nov 2025
Residual inflammation remains a key driver of recurrent events post-#ACS. Our @JCM_MDPI review examines how IL-1β, IL-6, NLRP3 & beyond may redefine secondary prevention.
@Mo_Allam90 @M_H_Abdelnabi @kwanleemd D.Sorajja D.Fortuin M.Bhakta
mdpi.com/3579950
7
638
31 Oct 2025
A joy to return to my @ASUEngineering roots as a guest speaker for the senior capstone course. Grateful to reconnect with the place that started my journey and meet the next generation of innovators. Thank you Dr. Pizziconi! @MayoAZCVFellows #ASUBME #FutureInnovators
1
4
199
30 Oct 2025
Honored to present and participate #TCT2025, and even more inspired by the incredible sessions from @MayoClinicCV and @DHHeartVascular colleagues and mentors.
@ChadiAyoub1 @M_H_Abdelnabi DFortuin @mnyoung1
3
11
697
Girish Pathangey retweeted
28 Oct 2025
I was honored to present several abstracts on SGLT2 benefits in TMVR and 3DE benefits in rheumatic TV along with a challenging coronary case in cases with the masters!
Next stop 🔜 #AHA25
#TCT2025 @TCTConference @crfheart @MayoClinicCV @MayoAZCVFellows
2
2
35
2,112
Girish Pathangey retweeted
6 Sep 2025
Wrangle CV risk at the #ASE2025 Carotid Rodeo! 🫀From plaque scoring to ultrasound vs. calcium scoring, this interactive session includes @stanhenkin & includes case presentations, audience Q&A, and expert panel insights. @ASE360
3
11
1,096
Girish Pathangey retweeted
6 Sep 2025
Checkout our latest “VO2 Max in Clinical Cardiology: Clinical Applications, Evidence Gaps, and Future Direction” discussing various clinical applications of VO2.
link.springer.com/article/10…
@MayoClinicCV
@MayoAZCVFellows
@ramziw_
@hoangnhat_pham
@GPathangey
@ChadiAyoub1
2
16
1,162
Girish Pathangey retweeted
5 Sep 2025
Extremely proud of our fellow representation at #ESCCongress2025 in Madrid! Excellent work!
1
6
47
2,840
3 Sep 2025
Thrilled to share our @MayoClinicProc first known case of constrictive pericarditis improved with rilonacept (IL-1 inhibition)—a potential new expanded role for targeted anti-inflammatory therapy. #Pericarditis #CardioTwitter @ChadiAyoub1 @MayoAZCVFellows
mayoclinicproceedings.org/ar…
2
7
759
Girish Pathangey retweeted
30 Aug 2025
David Simper, M.D, @EiadHabib @ramziw_ & @CNKanaan from @MayoClinic in AZ stopped by our #ESCCongress Booth A210 this morning. Swing by to learn more about research and educational programs #CardioTwitter @escardio w/ @MayoAZCVFellows
1
5
28
2,405
Girish Pathangey retweeted
25 Aug 2025
Proud of our team at Mayo Clinic Arizona who are working tirelessly to advance the science and improve patient care in the field of arterial aneurysms and dissection.@BernardBendokMD @thaiscoutinhoCV @stanhenkin @wellsbryanj @RLeLeiko @MayoAZCVFellows
4
7
46
2,765
Girish Pathangey retweeted
25 Aug 2025
Check out our latest study on colchicine post AF ablation!
@ramziw_ @hoangnhat_pham @MayoAZCVFellows @JAHA_AHA
ahajournals.org/doi/10.1161/…
3
7
36
2,901
Girish Pathangey retweeted
12 Aug 2025
Don't miss this special event - join Chadi Ayoub and I @ASE360 as we discuss foundational principles of #AI with @Microsoft AI's Ivan Tarapov (bit.ly/4fvbXZW) next Thursday. @SmithBIDMC @ppsengupta1 @alfonsowallermd @BidmcCvi @tabrahammd @iamritu @purviparwani
1
14
57
6,104
Girish Pathangey retweeted
13 Aug 2025
Amazing job @NicholeBrunton leading a comprehensive review on #IntermediateRiskPE! A must read for all #PE enthusiasts. @dinubalanescu @MayoClinicCV @mnyoung1 @EricSecemskyMD @SVM_tweets @ACCinTouch
#mdpijcm
#HighlyReviewed
Views 20678, Citations 13🙌
Risk Stratification and Management of Intermediate-Risk #Acute_Pulmonary_Embolism
👉mdpi.com/2623690
@MediPharma_MDPI
by Nichole Brunton et al. @stanhenkin
@NicholeBrunton
5
12
1,175
